Renaissance Technologies’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
2023
Q3
$772K Sell
2023
Q2
$225K Buy
2023
Q1
$245K Sell
2022
Q4
$445K Sell
2022
Q3
$813K Buy
2022
Q2
$840K Buy
2022
Q1
$673K Sell
2021
Q4
$1.12M Buy
2021
Q3
$1.51M Buy
2021
Q1
Sell
2020
Q4
$475K Buy
2020
Q3
$62K Buy
2019
Q1
Sell
2018
Q4
$547K Buy